Manning & Napier Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-96,678
| Closed | -$3.1M | – | 350 |
|
|
2017
Q1 | $3.1M | Buy |
96,678
+12,645
| +15% | +$406K | 0.02% | 251 |
|
|
2016
Q4 | $3.05M | Sell |
84,033
-29,403
| -26% | -$1.07M | 0.02% | 242 |
|
|
2016
Q3 | $5.22M | Sell |
113,436
-2,866
| -2% | -$132K | 0.03% | 190 |
|
|
2016
Q2 | $5.84M | Buy |
116,302
+5,110
| +5% | +$257K | 0.04% | 182 |
|
|
2016
Q1 | $5.95M | Sell |
111,192
-2,031
| -2% | -$109K | 0.03% | 176 |
|
|
2015
Q4 | $7.43M | Sell |
113,223
-222,570
| -66% | -$14.6M | 0.04% | 154 |
|
|
2015
Q3 | $19M | Sell |
335,793
-720
| -0.2% | -$40.6K | 0.1% | 97 |
|
|
2015
Q2 | $19.9M | Buy |
336,513
+25,090
| +8% | +$1.48M | 0.09% | 108 |
|
|
2015
Q1 | $19.4M | Buy |
311,423
+18,335
| +6% | +$1.14M | 0.09% | 115 |
|
|
2014
Q4 | $16.9M | Sell |
293,088
-86
| -0% | -$4.95K | 0.07% | 124 |
|
|
2014
Q3 | $15.8M | Buy |
293,174
+28,209
| +11% | +$1.52M | 0.07% | 136 |
|
|
2014
Q2 | $13.9M | Buy |
264,965
+33,713
| +15% | +$1.77M | 0.05% | 147 |
|
|
2014
Q1 | $12.2M | Sell |
231,252
-237
| -0.1% | -$12.5K | 0.05% | 153 |
|
|
2013
Q4 | $9.28M | Sell |
231,489
-23,467
| -9% | -$940K | 0.04% | 159 |
|
|
2013
Q3 | $9.63M | Buy |
254,956
+3,438
| +1% | +$130K | 0.05% | 161 |
|
|
2013
Q2 | $9.86M | Buy |
+251,518
| New | +$9.86M | 0.05% | 157 |
|